TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 199 filers reported holding TG THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $660,440 | -64.5% | 79,000 | +5.3% | 0.60% | -64.1% |
| Q2 2023 | $1,863,000 | +469169.5% | 75,000 | -21.1% | 1.67% | +322.5% |
| Q1 2023 | $397 | -99.9% | 95,000 | 0.0% | 0.40% | 0.0% |
| Q3 2022 | $397,000 | -84.1% | 95,000 | +26.7% | 0.40% | -68.2% |
| Q3 2021 | $2,496,000 | -14.2% | 75,000 | 0.0% | 1.24% | +11.0% |
| Q2 2021 | $2,909,000 | -19.5% | 75,000 | 0.0% | 1.12% | -17.5% |
| Q1 2021 | $3,615,000 | +2.6% | 75,000 | 0.0% | 1.36% | +3.6% |
| Q4 2020 | $3,525,000 | +112.1% | 75,000 | 0.0% | 1.31% | +100.9% |
| Q3 2020 | $1,662,000 | +42.4% | 75,000 | 0.0% | 0.65% | +33.5% |
| Q2 2020 | $1,167,000 | +107.3% | 75,000 | +15.4% | 0.49% | +63.0% |
| Q1 2020 | $563,000 | -4.6% | 65,000 | 0.0% | 0.30% | +6.4% |
| Q4 2019 | $590,000 | – | 65,000 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,880,323 | $38,633,000 | 2.30% |
| Eversept Partners, LP | 773,501 | $4,343,208 | 1.35% |
| Opaleye Management Inc. | 612,500 | $3,439,000 | 1.24% |
| BRIDGER MANAGEMENT, LLC | 2,334,196 | $13,107,000 | 1.08% |
| Sofinnova Investments, Inc. | 1,733,628 | $9,734,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 354,719 | $1,992,000 | 0.34% |
| 683 Capital Management, LLC | 400,000 | $2,246,000 | 0.25% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 649,460 | $3,646,000 | 0.23% |
| Artal Group S.A. | 900,000 | $5,054,000 | 0.20% |
| Frontier Wealth Management LLC | 226,750 | $1,273,000 | 0.19% |